CA
ASXC

Cetera Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Cetera Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,290
Closed -$23K – 979
2019
Q2 		$23K Hold
1,290
– – ﹤0.01% 921
2019
Q1 		$41K Buy
1,290
+152
+13% +$5.09K ﹤0.01% 997
2018
Q4 		$34K Buy
+1,138
New +$51.7K ﹤0.01% 829

Other funds holding ASXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Cetera Advisors's ASXC Position: Q3 2019 in Review

Cetera Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q3 2019, closing a stake of 1,290 shares — an estimated $23K sold.

Cetera Advisors first reported a position in ASXC in Q4 2018 and held it in 3 quarters. The position peaked at $41K in Q1 2019. 130 funds tracked by Wall St. Rank hold ASXC as of Q3 2019.

  • Cetera Advisors reported no remaining Asensus Surgical, Inc. position as of Q3 2019 after selling out during the quarter.
  • Cetera Advisors sold 1,290 Asensus Surgical, Inc. shares in Q3 2019, an estimated $23K.
  • Cetera Advisors first reported a position in Asensus Surgical, Inc. in Q4 2018 and held it in 3 quarters.
  • Cetera Advisors's Asensus Surgical, Inc. position peaked at $41K in Q1 2019.
  • 130 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2019.

Based on Cetera Advisors's 13F filing for Q3 2019, filed 6 Nov 2019.